Ionis Pharmaceuticals IONS Total Costs & Expenses
Total Costs & Expenses at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's total costs & expenses?
- Ionis Pharmaceuticals (IONS) reported total costs & expenses of $363.52M in Q1 2026.
- How has Ionis Pharmaceuticals's total costs & expenses changed year-over-year?
- Ionis Pharmaceuticals's total costs & expenses increased by 30.5% year-over-year, from $278.47M to $363.52M.
- What is the long-term trend for Ionis Pharmaceuticals's total costs & expenses?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's total costs & expenses has grown at a 7.8% compound annual growth rate (CAGR), from $1.14B to $1.33B.
- What does total costs & expenses mean?
- The total sum of all operating costs and expenses incurred during the period.
- How do you interpret total costs & expenses?
- A decrease relative to revenue indicates improved operational efficiency and cost control.
- How does total costs & expenses compare across companies?
- Standard total operating expense metric used to evaluate overall cost structure.